Brief: Aptar Awarded Us FDA Contract To Study Opportunities For Low Global Warming Potential Propellants For Metered Dose Inhalers
04/12/2023 13:51
Dec 4 (Reuters) - AptarGroup Inc ATR.N :
* APTAR AWARDED US FDA CONTRACT TO STUDY OPPORTUNITIES FOR
LOW
GLOBAL WARMING POTENTIAL PROPELLANTS FOR METERED DOSE INHALERS
Source text for Eikon: ID:nBwbTMvjLa
Further company coverage: ATR.N
((reuters.briefs@thomsonreuters.com;))
Recent news on AptarGroup
See all newsBrief: Aptargroup Note Decree Of President Of Russian Federation
Russia puts Aptar Europe Holding under temporary administration
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Aptargroup Inc reports results for the quarter ended June 30 - Earnings Summary
Aptar Q2 sales beat estimates on strength in consumer healthcare and injectables